drugset / Trial / NCT02231944

An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients

NCT02231944 ↗

Phase 3 Completed Bio Products Laboratory
Treatment

Summary

To compare the first and second recovery assessments on Replenine®-VF and to evaluate recovery of different batches if patients changed batches during the study. To evaluate Replenine®-VF in terms of long-term clinical efficacy, tolerance and safety

Timeline

Start
1997-07
Primary completion
2003-10
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Replenine®-VF Protein / enzyme biologic — —

Indications